| Quarter | Score |
|---|---|
| 2013-Q2 | 49.4 |
| 2013-Q3 | 48.4 |
| 2013-Q4 | 62.0 |
| 2014-Q1 | 48.7 |
| 2014-Q2 | 48.2 |
| 2014-Q3 | 49.0 |
| 2018-Q1 | 52.0 |
| 2018-Q2 | 50.4 |
| 2018-Q3 | 52.1 |
| 2019-Q2 | 52.8 |
| 2022-Q3 | 41.0 |
| 2022-Q4 | 50.1 |
| 2023-Q1 | 49.0 |
| 2023-Q2 | 63.9 |
| 2023-Q3 | 48.1 |
| 2023-Q4 | 36.0 |
| 2024-Q1 | 50.1 |
| 2024-Q2 | 73.1 |
| 2024-Q3 | 69.4 |
| 2024-Q4 | 68.2 |
| 2025-Q1 | 67.3 |
| 2025-Q2 | 68.8 |
| 2025-Q3 | 67.8 |
| 2025-Q4 | 48.1 |
| 2026-Q1 | 50.8 |
| 2026-Q2 | 52.9 |
Funds reducing exposure or consensus momentum fading
Trading 25.4% below funds' estimated purchase price
1 of 16 tracked funds hold CZR. Avg conviction: 0.9%. Net holding. First tracked at $39.74 (current -25.4% vs tracked).
Benchmark comparison unavailable
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 16 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Icahn Capital | 0.9% | Hold |